Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.
Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.
Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.
Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.
Humana Inc. (NYSE: HUM) released its 2022 Impact Report, emphasizing its commitment to improving healthcare equity and accessibility. Key highlights include a 26% reduction in avoidable hospitalizations for members using integrated services like CenterWell. In 2022, the company screened 1.24 million individuals for social health needs and invested over $22.5 million in community initiatives. Humana surpassed its environmental goals with a 35% reduction in greenhouse gas emissions and a 64% waste diversion rate. The report outlines efforts to enhance diversity, equity, and inclusion within the organization, with over 94% of executive leaders completing competency training.
Humana Inc. (NYSE: HUM) has invested
Humana Inc. (NYSE: HUM) will announce its financial results for the first quarter of 2023 on April 26, 2023, at 6:30 AM ET. A conference call is scheduled for the same day at 9:00 AM ET to discuss these results and provide earnings guidance for 2023. Investors can participate via telephone after registering in advance. A webcast will also be available on Humana’s Investor Relations page. The earnings news release will include non-GAAP financial measures, with a reconciliation provided. Humana aims to improve health care delivery and lower costs, emphasizing their support for health care professionals and integrated care delivery.
Humana (NYSE: HUM) has pledged a total of $15 million to Thomas Jefferson University to enhance community health and promote health equity. Through the establishment of the Humana Insights for Action Fund, which includes a $3 million commitment, the partnership aims to leverage data analytics and research to address health disparities in underserved populations. Additionally, a $12 million endowment will fund three key positions focused on advancing health equity. This initiative underscores Humana's dedication to fostering equitable healthcare solutions across marginalized communities.
The Humana Foundation has appointed David A. Jones Jr. as the new Chairman of the Board, effective April 1, 2023. Jones has over 26 years of service with the Foundation and has been a board member of Humana Inc. since 1993. He succeeds Bruce Broussard, who will remain on the Board but step down as Chairman. Jones aims to enhance the Foundation's efforts in promoting health equity and community wellness. The Foundation, established in 1981, focuses on eliminating barriers to health and fostering collaborations to support underserved communities.
Humana Healthy Horizons, the Medicaid division of Humana Inc. (NYSE: HUM), contributed over $1 million to Louisiana non-profits in the past year, supporting initiatives focused on health, housing, education, and food security. Among the recipients are organizations like the American Heart Association and Access Health Louisiana. Regional President Lori Dunne emphasized the company's commitment to improving community health. Humana serves over 437,000 Louisianans through various healthcare programs and has been selected to manage Medicaid for beneficiaries in the state starting in 2023.
Humana Inc. (NYSE: HUM) has successfully completed a public offering of $1.25 billion in senior notes. This includes $500 million of 5.700% notes maturing in 2026 and $750 million of 5.500% notes maturing in 2053. The anticipated net proceeds amount to approximately $1.211 billion, primarily to repay a $500 million Delayed Draw Term Loan. Any excess funds will be allocated for general corporate purposes. A cautionary statement highlights potential risks associated with Humana's financial health, strategic initiatives, and regulatory compliance amidst ongoing challenges posed by the COVID-19 pandemic.
An independent analysis from Florida State University reveals that Humana Inc. (NYSE: HUM) significantly impacts Florida's economy, contributing approximately
Humana Inc. (NYSE: HUM) has been recommended by the Indiana Family and Social Services Administration to receive a contract for the Medicaid Managed Long Term Services and Supports (MLTSS) program in Indiana, beginning in 2024. This contract allows Humana to expand its services, already supporting nearly 350,000 members in the state through various health plans. The initiative emphasizes a person-centered approach, leveraging technology and data analytics to enhance health outcomes and address disparities. The contract's initial term is four years, with options for renewal, allowing Humana to continue serving dually eligible Medicaid and Medicare members.
Humana Inc. (NYSE: HUM) and Aledade have announced a 10-year partnership aimed at enhancing value-based primary care for Medicare Advantage members. This collaboration builds on a successful relationship since 2019, which resulted in a 5% reduction in hospitalizations and 12% decrease in readmissions. By 2022, over 100,000 patients benefited from this value-based approach. The partnership will gradually expand through existing and new agreements, focusing on comprehensive care and risk sharing. Aledade aims to empower independent practices with technology and support, having generated over $1.2 billion in healthcare savings to date.